Royalty Pharma PLC (FRA:RPD)
€ 49.08 -0.42 (-0.86%) Market Cap: 21.95 Bil Enterprise Value: 28.21 Bil PE Ratio: 32.42 PB Ratio: 3.71 GF Score: 72/100

Royalty Pharma PLC at Cowen Health Care Conference Transcript

Mar 7, 2023 / 04:10 PM GMT
Release Date Price: €32.47 (-1.77%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RPRX.OQ - Royalty Pharma PLC
Royalty Pharma PLC at Cowen Health Care Conference
Mar 07, 2023 / 04:10PM GMT

=====================
Corporate Participants
=====================
* Terrance Coyne
Royalty Pharma plc - Executive VP & CFO
* Christopher Hite
Royalty Pharma plc - Vice Chairman & Executive VP
* Marshall Urist
Royalty Pharma plc - Executive VP and Head of Research & Investments

=====================
Conference Call Participants
=====================
* Stephen Scala
TD Cowen, Research Division - MD & Senior Research Analyst
* Kathleen Miner
TD Cowen, Research Division - Former Director

=====================
Questions and Answers
--------------------------------------------------------------------------------
Stephen Scala, TD Cowen, Research Division - MD & Senior Research Analyst [1]
--------------------------------------------------------------------------------
Good morning once again. We'd like
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot